Weifeng Tan
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
-
- Algal biology and biofuel production
Papers in
-
- Ubiquitin and proteasome pathways 2
- Inflammasome and immune disorders 2
- Surgery 8
- Cholangiocarcinoma and Gallbladder Cancer Studies 7
- Co-authors
- Raymond Lau (1 shared paper)Xue Chen (1 shared paper)Wei Ning Chen (1 shared paper)Iqbal Hossain (1 shared paper)Xinwei Yang (7 shared papers)Mengchao Wu (8 shared papers)Yongjie Zhang (2 shared papers)Lu Wang (3 shared papers)
- Journals
- Optics Letters (2 papers)Cancer Letters (1 paper)Journal of Functional Foods (1 paper)Chemico-Biological Interactions (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Weifeng Tan
32 papers receiving 602 citations
Peers
Comparison fields: 5 of 89
- Hepatology 89
- Renewable Energy, Sustainability and the Environment 90
- Cancer Research 69
- Oncology 91
- Pathology and Forensic Medicine 55
Countries citing papers authored by Weifeng Tan
This map shows the geographic impact of Weifeng Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifeng Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifeng Tan more than expected).
Fields of papers citing papers by Weifeng Tan
This network shows the impact of papers produced by Weifeng Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifeng Tan. The network helps show where Weifeng Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Weifeng Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 99 | |
| 2 | 2011 | 51 | |
| 3 | 2010 | 47 | |
| 4 | 2010 | 37 | |
| 5 | 2019 | 37 | |
| 6 | 2019 | 31 | |
| 7 | 2011 | 30 | |
| 8 | 2016 | 28 | |
| 9 | 2021 | 26 | |
| 10 | 2011 | 25 | |
| 11 | 2020 | 21 | |
| 12 | 2022 | 17 | |
| 13 | 2018 | 16 | |
| 14 | 2018 | 16 | |
| 15 | 2022 | 15 | |
| 16 | 2022 | 14 | |
| 17 | 2013 | 14 | |
| 18 | 2023 | 13 | |
| 19 | 2009 | 12 | |
| 20 | CCL20 is overexpressed in hepatocellular carcinoma with bile duct tumor thrombus and correlates negatively with surgical outcome. | 2018 | 10 |
About Weifeng Tan
Weifeng Tan is a scholar working on Molecular Biology, Surgery, Oncology, Epidemiology and Hepatology, having authored 37 papers that have together received 610 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Solid State Laser Technologies (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Ubiquitin and proteasome pathways (2 papers), Diet, Metabolism, and Disease (2 papers) and Inflammasome and immune disorders (2 papers). The work is most often cited by research in Hepatology (89 citations), Renewable Energy, Sustainability and the Environment (90 citations), Cancer Research (69 citations), Oncology (91 citations) and Pathology and Forensic Medicine (55 citations). Weifeng Tan has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Raymond Lau, Xue Chen, Wei Ning Chen, Iqbal Hossain, Xinwei Yang, Mengchao Wu, Yongjie Zhang, Lu Wang, Xiaoqing Jiang and Yingmei Zhang. Their work appears in journals such as Optics Letters, Cancer Letters, Journal of Functional Foods, Chemico-Biological Interactions and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.